|Table of Contents|

Analysis of Key Pathways,Genes and Immune Cell Infiltration in Metastatic Esophageal Squamous Cell Carcinoma Based on Bioinformatics(PDF)

《南京师大学报(自然科学版)》[ISSN:1001-4616/CN:32-1239/N]

Issue:
2023年02期
Page:
77-84
Research Field:
生物学
Publishing date:

Info

Title:
Analysis of Key Pathways,Genes and Immune Cell Infiltration in Metastatic Esophageal Squamous Cell Carcinoma Based on Bioinformatics
Author(s):
Wang Zhangjiao1Shen Yong2Xu Qingxia2
(1.Henan University of Chinese Medicine,The Second Affiliated Hospital of Henan University of TCM,Zhengzhou 450000,China)
(2.Department of Clinical Laboratory,Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital,Zhengzhou 450008,China)
Keywords:
esophageal carcinoma biomarker immune infiltration bioinformatics analysis
PACS:
R735.1
DOI:
10.3969/j.issn.1001-4616.2023.02.010
Abstract:
Esophageal squamous cell carcinoma is one of the common malignant tumors, to systematically and comprehensively explore the characteristics of differentially expressed genes and immune cells in esophageal carcinoma by bioinformatics. Four esophageal cancer data sets were obtained from GEO database, and the differences and gene enrichment were analyzed, and the selected core genes were further explored. A total of 244 differentially expressed genes(DEGs)were screened, including 164 up-regulated genes and 80 down-regulated genes, which were mainly enriched in extracellular region and extracellular space, and related to tumor invasion and metastasis. KEGG results showed that DEGs were mainly enriched in PI3K-Akt signal pathway and extracellular matrix(ECM)receptor interaction signal pathway. And it was found that three hub genes(CXCL8, MMP9 and MMP13)were highly expressed in ESCC. The results of immune infiltration showed that macrophages and resting dendritic cells increased significantly, while mast cells and monocytes decreased significantly. In conclusion, three hub genes and immune infiltrating cells may play an important role in ESCC, and are expected to become potential tumor markers of ESCC and be used in the diagnosis and treatment of ESCC.

References:

[1]SUNG H,FERLAY J,SIEGEL R L,et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA:a cancer journal for clinicians,2021,71(3):209-249.
[2]LI J,XU J,ZHENG Y,et al. Esophageal cancer:Epidemiology,risk factors and screening[J]. Chinese journal of cancer research,2021,33(5):535-547.
[3]KAKEJI Y,OSHIKIRI T,TAKIGUCHI G,et al. Multimodality approaches to control esophageal cancer:development of chemoradiotherapy,chemotherapy,and immunotherapy[J]. Esophagus,2021,18(1):25-32.
[4]YANG J,LIU X,CAO S,et al. Understanding esophageal cancer:the challenges and opportunities for the next decade[J]. Frontiers in oncology,2020,10(17):27-40.
[5]ZHENG Y,CHEN Z,HAN Y,et al. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment[J]. Nature communications,2020,11(1):6268-6285.
[6]CHEN H,WU J,LU L,et al. Identification of hub genes associated with immune infiltration and predict prognosis in hepatocellular carcinoma via bioinformatics approaches[J]. Frontiers in genetics,2020,11(57):62-79.
[7]VAN IJZENDOORN D G P,SZUHAI K,BRIAIRE-DE BRUIJN I H,et al. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas[J]. PLoS computational biology,2019,15(2):6826-6845.
[8]LING B,LIAO X,HUANG Y,et al. Identification of prognostic markers of lung cancer through bioinformatics analysis and in vitro experiments[J]. International journal of oncology,2020,56(1):193-205.
[9]SZKLARCZYK D,GABLE A L,LYON D,et al. STRING v11:protein-protein association networks with increased coverage,supporting functional discovery in genome-wide experimental datasets[J]. Nucleic acids research,2019,47(D1):D607-D613.
[10]CHIN C H,CHEN S H,WU H H,et al. cytoHubba:identifying hub objects and sub-networks from complex interactome[J]. BMC systems biology,2014,8(Suppl 4):S11-S18.
[11]HANAHAN D,WEINBERG R A. Hallmarks of cancer:the next generation[J]. Cell,2011,144(5):646-674.
[12]JIANG N,DAI Q,SU X,et al. Role of PI3K/AKT pathway in cancer:the framework of malignant behavior[J]. Molecular biology reports,2020,47(6):4587-4629.
[13]BAO Y,WANG L,SHI L,et al. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer[J]. Cellular & molecular biology letters,2019,24(6):38-58.
[14]RAPOPORT B L,STEEL H C,THERON A J,et al. Role of the neutrophil in the pathogenesis of advanced cancer and impaired responsiveness to therapy[J]. Molecules(Basel,Switzerland),2020,25(7):E1618-E1640.
[15]HA H,DEBNATH B,NEAMATI N. Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases[J]. Theranostics,2017,7(6):1543-1588.
[16]田倩,曹润怿,王方方,等. CXCL13 参与AR促进前列腺癌细胞体内异种移植瘤的生长[J]. 南京师大学报(自然科学版),2018,41(3):70-77.
[17]BILUSIC M,HEERY C R,COLLINS J M,et al. Phase I trial of HuMax-IL8(BMS-986253),an anti-IL-8 monoclonal antibody,in patients with metastatic or unresectable solid tumors[J]. Journal for immunotherapy of cancer,2019,7(1):240-248.
[18]LIN C,HE H,LIU H,et al. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer[J]. Gut,2019,68(10):1764-1773.
[19]XIONG X,LIAO X,QIU S,et al. CXCL8 in tumor biology and its implications for clinical translation[J]. Frontiers in molecular biosciences,2022,9(7):846-859.
[20]LIN C H,CHENG H W,MA H P,et al. Thrombin induces NF-kappaB activation and IL-8/CXCL8 expression in lung epithelial cells by a Rac1-dependent PI3K/Akt pathway[J]. The journal of biological chemistry,2011,286(12):10483-10494.
[21]YANG L,LIU L,GAO H,et al. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis[J]. Journal of hematology & oncology,2017,10(1):159-180.
[22]REIS S T,LEITE K R M,PIOVESAN L F,et al. Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer[J]. BMC urology,2012,12(11):18-23.
[23]INOUE K,SLATON J W,EVE B Y,et al. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer[J]. Clinical cancer research:an official journal of the american association for cancer research,2000,6(5):2104-2119.
[24]JIA X,LU M,RUI C,et al. Consensus-expressed CXCL8 and MMP9 identified by meta-analyzed perineural invasion gene signature in gastric cancer microarray data[J]. Frontiers in genetics,2019,10(7):851-858.
[25]JIANG C H,LIANG W H,LI F P,et al. Distribution and prognostic impact of M1 macrophage on esophageal squamous cell carcinoma[J]. Carcinogenesis,2021,42(4):537-545.
[26]MEHLA K,SINGH P K. Metabolic regulation of macrophage polarization in cancer[J]. Trends in cancer,2019,5(12):822-834.
[27]XU F,WEI Y,TANG Z,et al. Tumor-associated macrophages in lung cancer:Friend or foe?(Review)[J]. Molecular medicine reports,2020,22(5):4107-4115.
[28]CHEN S R,LUO Y P,ZHANG J K,et al. Study on immune function of dendritic cells in patients with esophageal carcinoma[J]. World journal of gastroenterology,2004,10(7):934-939.
[29]KOCIÁN P,EDIVCOVÁ M,DRGÁACˇ J,et al. Tumor-infiltrating lymphocytes and dendritic cells in human colorectal cancer:their relationship to KRAS mutational status and disease recurrence[J]. Human immunology,2011,72(11):1022-1028.
[30]宋政文,赵智辉. 靶向树突状细胞的结肠癌肿瘤疫苗的制备[J]. 南京师大学报(自然科学版),2020,43(3):112-119.
[31]DERAKHSHANI A,VAHIDIAN F,ALIHASANZADEH M,et al. Mast cells:A double-edged sword in cancer[J]. Immunology letters,2019,209(5):28-35.
[32]HAN L,JIA Y,SONG Q,et al. Prognostic significance of preoperative absolute peripheral monocyte count in esophageal squamous cell carcinoma[J]. Diseases of the esophagus:official journal of the international society for diseases of the esophagus,2016,29(7):740-746.
[33]SIMONI Y,BECHT E,FEHLINGS M,et al. Bystander CD8+T cells are abundant and phenotypically distinct in human tumour infiltrates[J]. Nature,2018,557(7706):575-579.

Memo

Memo:
-
Last Update: 2023-06-15